在基因病理学中使用烯的更安全和可持续的替代品:综合性审查
Yogalakshmi Devendrababu1, Vignesh Vikram2, Tamilarasi Anandbabu2
1Sri Ramachandra Institute of Higher Education and Research, Chennai, India.
Journal of applied toxicology : JAT
|December 13, 2025
概括
烯是组织病理学中的标准,但对健康构成风险. 本综述探讨了更安全的替代方案,以保持实验室人员的诊断准确性.
科学领域:
- 组织病理学 组织病理学
- 毒理学 毒理学 毒理学
- 化学安全 化学安全
背景情况:
- 烯是一种芳香的碳化合物,在组织病理学中至关重要.
- 它的有毒排放对实验室人员的健康构成重大风险.
- 这就需要探索更安全的替代品.
研究的目的:
- 审查在组织病理学中使用烯的更安全替代品.
- 识别能够保持诊断准确性和生物安全性的药物.
- 为了评估成本效益和适合常规实验室使用.
主要方法:
- 对过去几十年研究的文献综述.
- 专注于天然提取物和合成化合物.
- 对诊断疗效和生物安全数据的评估.
主要成果:
- 目前有限的替代品与烯的疗效相匹配.
- 一些代理商在平衡安全性和性能方面表现有前途.
- 目前正在进行的研究旨在提高生物安全性和成本效益.
结论:
- 更安全的烯替代品对于他的病理学至关重要.
- 将诊断准确性与生物安全性之间的平衡是关键.
- 需要进一步的研究才能广泛采用.
相关概念视频
01:25Mutagenicity and Carcinogenicity
2.0K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.0K
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
260
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
260